Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04887506
Title TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Tavanta Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SWE | POL | HUN | GBR | FRA | ESP


No variant requirements are available.